In hepatocellular carcinoma (HCC), both plasma TGF-β1 and circulating TGF-β1-responsive regulatory T cells are independently prognostic factors for worse outcomes [24,25]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.